Agency Forms Undergoing Paperwork Reduction Act Review, 40702-40703 [2016-14725]
Download as PDF
<![CDATA[
40702
Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–16UW]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
Proposed Project
Case Investigation of Cervical Cancer
(CICC) Study—New—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Invasive cervical cancer occurs when
cervical cancer spreads from the surface
of the cervix to deeper cervical tissue or
to other parts of the body. In the United
States, invasive cervical cancer is
largely preventable due to the
availability of (1) screening tests, which
allow for early detection and treatment
of cervical pre-cancers, and (2) a vaccine
that prevents infection with types of
human papillomavirus (HPV) which are
associated with over 80% of cervical
cancers. However, one previous study
showed that half of the women who
developed cervical cancer had not been
adequately screened, and a more recent
study showed that there were still
approximately 8 million women in the
U.S. who had not been screened for
cervical cancer in the previous five
years.
CDC plans to conduct the Case
Investigation of Cervical Cancer (CICC)
Study to improve understanding of the
facilitators and barriers to cervical
cancer screening and timely follow-up
of abnormal test results. The proposed
project will identify women recently
diagnosed with invasive cervical cancer
(2014–2016) through cancer registries in
three states. Each registry will enroll
cancer survivors within that state who
consent to participate in the study.
Three types of data will be collected.
(1) Existing cancer registry data will
provide information on tumor
characteristics, diagnosis, and stage of
cancer. This will be used to describe the
characteristics of the sample of
survivors and for the identification of
the eligible sample. (2) Participants will
be asked to complete a survey. The
purpose of the survey is to identify selfreported barriers and facilitators to
screening and care, and to examine
recall of screening tests. (3) Participants
will also be asked to complete medical
release and healthcare source forms to
permit medical chart abstraction. The
purpose of the medical chart abstraction
is to obtain detailed clinical information
about all screening and treatment prior
to diagnosis. Together the information
from these three sources of data will be
used to identify opportunities for
intervention to reach women and their
providers in order to increase screening
and appropriate follow-up care.
Based on preliminary data from three
state cancer registries, a total of
approximately 1,670 eligible cervical
cancer survivors are eligible for
participation. CDC estimates a survey
response rate of 50% of across the entire
sample (N = 835) followed by an 80%
response rate to the medical release and
healthcare source forms (N = 668).
These estimates yield approximately
668 women with complete data for both
surveys and chart abstraction. The
estimated burden per response for
completing the mail-in questionnaire is
15 minutes. The estimated burden per
response for the medical release and
healthcare source forms is five minutes.
For each CICC participant, the medical
chart abstraction process is expected to
require follow-up with 1–5 (average of
3) health care providers (N = 2,004). The
estimated burden for support activities
conducted by office assistants at the
health care facilities associated with
each medical record abstraction is five
minutes.
OMB approval is requested for two
years. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annualized burden hours are 217.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
mstockstill on DSK3G9T082PROD with NOTICES
Type of respondents
Form name
Invasive cervical cancer survivors ..................
Case Investigation of Cervical Cancer Study
Survey.
Medical Release and Healthcare Source
Forms.
Support for medical record abstraction ..........
Health care office assistant ............................
VerDate Sep<11>2014
20:02 Jun 21, 2016
Jkt 238001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\22JNN1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hours)
418
1
15/60
314
1
5/60
1,002
1
5/60
22JNN1
Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–14725 Filed 6–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
EDT, July 14, 2016; 9:00 a.m.–12:00
p.m., EDT, July 15, 2016.
Place: Centers for Disease Control and
Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE., Atlanta, Georgia
30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 300
people. Please register for the meeting at
www.cdc.gov/hicpac.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda
will include updates on CDC’s activities
for prevention of healthcare associated
infections (HAIs), updates on
antimicrobial stewardship, an update on
Draft Guideline for Prevention of
Infections in Healthcare Personnel, and
an update from the workgroup for
considerations on endoscope
reprocessing.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Erin Stone, M.S., HICPAC, Division of
VerDate Sep<11>2014
20:02 Jun 21, 2016
Jkt 238001
40703
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE., Mailstop
A–07, Atlanta, Georgia 30333 Telephone
(404) 639–4045, Email: hicpac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Proposed Project
Health Risks from Using Private Wells
for Drinking Water—New — National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–14788 Filed 6–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–16TL]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Background and Brief Description
The Safe Drinking Water Act of 1974
(SDWA) ensures that most Americans
are provided access to water that meets
established public health standards.
However, for over 38 million Americans
who rely on private wells or other
drinking water not protected by the
SDWA (herein referred to as private
wells), that is not the case. There is no
comprehensive knowledge about the
locations of private wells, the
populations served by these sources,
potential contaminants that might be
present in private well water in specific
areas of the country, or the potential
health risks associated with drinking
water from these sources.
The purpose of this new generic
clearance information collection request
is to assess the health risks associated
with exposure to contaminants in
drinking water from private wells across
varied geographic areas of the United
States in partnership with the
requesting agency (state, territorial,
local, or tribal health department). The
information obtained from these
investigations will be used to describe
health risks from exposure to
contaminants in drinking water from
private wells within a defined time
period and geographic distribution. This
information will be used to inform
public health protection activities
conducted by the requesting agencies.
The respondents are defined as adults
at least 18 years old, who use private
wells for drinking water, who are
willing to receive and return a tap water
sampling kit and urine specimen kit or
to provide a blood specimen, and who
are willing to answer survey questions.
They will be recruited from geographic
areas of interest as defined by the
requesting agency.
Based on our historical activities, we
estimate that CDC will conduct up to 10
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Pages 40702-40703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14725]
[[Page 40702]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-16UW]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Case Investigation of Cervical Cancer (CICC) Study--New--National
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Invasive cervical cancer occurs when cervical cancer spreads from
the surface of the cervix to deeper cervical tissue or to other parts
of the body. In the United States, invasive cervical cancer is largely
preventable due to the availability of (1) screening tests, which allow
for early detection and treatment of cervical pre-cancers, and (2) a
vaccine that prevents infection with types of human papillomavirus
(HPV) which are associated with over 80% of cervical cancers. However,
one previous study showed that half of the women who developed cervical
cancer had not been adequately screened, and a more recent study showed
that there were still approximately 8 million women in the U.S. who had
not been screened for cervical cancer in the previous five years.
CDC plans to conduct the Case Investigation of Cervical Cancer
(CICC) Study to improve understanding of the facilitators and barriers
to cervical cancer screening and timely follow-up of abnormal test
results. The proposed project will identify women recently diagnosed
with invasive cervical cancer (2014-2016) through cancer registries in
three states. Each registry will enroll cancer survivors within that
state who consent to participate in the study.
Three types of data will be collected. (1) Existing cancer registry
data will provide information on tumor characteristics, diagnosis, and
stage of cancer. This will be used to describe the characteristics of
the sample of survivors and for the identification of the eligible
sample. (2) Participants will be asked to complete a survey. The
purpose of the survey is to identify self-reported barriers and
facilitators to screening and care, and to examine recall of screening
tests. (3) Participants will also be asked to complete medical release
and healthcare source forms to permit medical chart abstraction. The
purpose of the medical chart abstraction is to obtain detailed clinical
information about all screening and treatment prior to diagnosis.
Together the information from these three sources of data will be used
to identify opportunities for intervention to reach women and their
providers in order to increase screening and appropriate follow-up
care.
Based on preliminary data from three state cancer registries, a
total of approximately 1,670 eligible cervical cancer survivors are
eligible for participation. CDC estimates a survey response rate of 50%
of across the entire sample (N = 835) followed by an 80% response rate
to the medical release and healthcare source forms (N = 668). These
estimates yield approximately 668 women with complete data for both
surveys and chart abstraction. The estimated burden per response for
completing the mail-in questionnaire is 15 minutes. The estimated
burden per response for the medical release and healthcare source forms
is five minutes. For each CICC participant, the medical chart
abstraction process is expected to require follow-up with 1-5 (average
of 3) health care providers (N = 2,004). The estimated burden for
support activities conducted by office assistants at the health care
facilities associated with each medical record abstraction is five
minutes.
OMB approval is requested for two years. Participation is voluntary
and there are no costs to respondents other than their time. The total
estimated annualized burden hours are 217.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Invasive cervical cancer survivors.... Case Investigation of 418 1 15/60
Cervical Cancer Study
Survey.
Medical Release and 314 1 5/60
Healthcare Source Forms.
Health care office assistant.......... Support for medical 1,002 1 5/60
record abstraction.
----------------------------------------------------------------------------------------------------------------
[[Page 40703]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-14725 Filed 6-21-16; 8:45 am]
BILLING CODE 4163-18-P
